Trial Profile
Analysis of risk factors for severe adverse events of chemotherapy with pemetrexed and comparison of adverse event occurrence according to renal function.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary)
- Indications Renal impairment
- Focus Adverse reactions
- 22 Dec 2015 New trial record